Select for export Psychedelic Drugs: A Mind-expanding Hallucinogens Abstract available at the source but not redistributed here. Read at source. Details DOI 10.55229/ijbs.v27i1.13 Copy citation Copy BibTeX Indian Journal of Behavioural Sciences 2024-03-21 Shreyasee Das, Rahul Shil OpenAlex Published psilocybin DepressionPTSDAddiction Other More
Select for export Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811241237870 PubMed 38520045 Copy citation Copy BibTeX Journal of Psychopharmacology 2024-03-21 David Erritzøe, Tommaso Barba, Meg J. Spriggs, Fernando E. Rosas, David Nutt, Robin Carhart-Harris OpenAlex Published psilocybin DepressionAnxietyChronic Pain Clinical Trial More
Select for export Psychedelic Renaissance: Evidence and Culture Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2024.04.4.39 Copy citation Copy BibTeX Psychiatric News 2024-03-20 Adrian Preda OpenAlex Published psilocybin DepressionPTSDNeuroplasticity Clinical Trial More
Select for export Scanning the new frontier of mental health: psychedelic brain imaging Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1042/bio_2023_171 Copy citation Copy BibTeX The Biochemist 2024-03-13 Natalie Ertl, Matthew B. Wall OpenAlex Published psilocybin DepressionAnxietyAddiction Other More
Select for export Psychedelic drugs and the law: What’s next? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1146/knowable-031424-2 Copy citation Copy BibTeX Knowable Magazine 2024-03-13 Ben Seal OpenAlex Published psilocybinpsilocin DepressionAnxietyPTSD Systematic Review More
Select for export The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1371/journal.pone.0300501 PubMed 38483940 Copy citation Copy BibTeX PLoS ONE 2024-03-13 Adam W. Levin, Rafael Lancelotta, Nathan D. Sepeda, Natalie Gukasyan, Sandeep M. Nayak, Theodore L. Wagener OpenAlex Published psilocybin DepressionMystical ExperienceClinical Trial Randomized Controlled Trial More
Select for export The Mystical Experience Questionnaire 4-Item and Challenging Experience Questionnaire 7-Item. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1089/psymed.2023.0046 PubMed 40051759 Copy citation Copy BibTeX Unknown journal 2024-03-10 Strickland JC, Garcia-Romeu A, Johnson MW. Europe PMC Published psilocybin DepressionAnxietyMystical Experience Other More
Select for export Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive Disorder Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s11469-024-01253-9 Copy citation Copy BibTeX International Journal of Mental Health and Addiction 2024-03-06 Brandon Weiss, Leor Roseman, Bruna Giribaldi, David Nutt, Robin Carhart-Harris, David Erritzøe OpenAlex Published psilocybin DepressionAnxietyMechanism of Action Clinical Trial More
Select for export Patients with bipolar II disorder benefit from single dose of psilocybin Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/pu.31143 Copy citation Copy BibTeX The Brown University Psychopharmacology Update 2024-03-03 Authors unavailable OpenAlex Published psilocybin DepressionPharmacology Clinical Trial More
Select for export Where do the symptoms come from in depression? Topography and dynamics matter. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/braincomms/fcae067 PubMed 38515441 Copy citation Copy BibTeX Unknown journal 2024-03-03 Çatal Y, Northoff G. Europe PMC Published psilocybin DepressionTreatment-Resistant Depression Other More
Select for export A Systematic Review of the Neurocognitive Effects of Psychedelics in Healthy Populations: Implications for Depressive Disorders and Post-Traumatic Stress Disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3390/brainsci14030248 PubMed 38539636 Copy citation Copy BibTeX Unknown journal 2024-03-02 Velit-Salazar MR, Shiroma PR, Cherian E. Europe PMC Published psilocybin DepressionPTSDEmotional Processing Systematic Review More
Select for export Psilocybin zur Behandlung depressiver Erkrankungen No abstract availability was recorded for this entry. Details DOI 10.1007/s12268-024-2157-2 Copy citation Copy BibTeX BIOspektrum 2024-02-29 Henning Hintzsche OpenAlex Published psilocybin Depression Other More
Select for export Psychedelic Therapy: A Primer for Primary Care Clinicians-Historical Perspective and Overview Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/mjt.0000000000001727 PubMed 38518266 Copy citation Copy BibTeX American Journal of Therapeutics 2024-02-29 Burton J. Tabaac, Kenneth Shinozuka, Alejandro Arenas, Bryce D. Beutler, Kirsten Cherian, Viviana D. Evans OpenAlex Published psilocybin DepressionAnxietyPTSD Randomized Controlled Trial More
Select for export Psychedelic Therapy: A Primer for Primary Care Clinicians-Psilocybin Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/mjt.0000000000001724 PubMed 38518269 Copy citation Copy BibTeX American Journal of Therapeutics 2024-02-29 Burton J. Tabaac, Kenneth Shinozuka, Alejandro Arenas, Bryce D. Beutler, Kirsten Cherian, Viviana D. Evans OpenAlex Published psilocybin DepressionAnxietyAddiction Clinical Trial More
Select for export Impact of Psilocybin on Peripheral Cytokine Production Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1089/psymed.2023.0039 PubMed 40051582 Copy citation Copy BibTeX Psychedelic Medicine 2024-02-27 Dana DiRenzo, Frederick S. Barrett, Jamie Perin, Erika Darrah, Lisa Christopher-Stine, Roland R. Griffiths OpenAlex Published psilocybin DepressionAnxietyAddiction Randomized Controlled Trial More
Select for export Predicting the outcome of psilocybin treatment for depression from baseline fMRI functional connectivity No abstract availability was recorded for this entry. Details DOI 10.1016/j.jad.2024.02.089 PubMed 38423367 Copy citation Copy BibTeX Journal of Affective Disorders 2024-02-26 Débora Copa, David Erritzøe, Bruna Giribaldi, David Nutt, Robin Carhart-Harris, Enzo Tagliazucchi OpenAlex Published psilocybin DepressionBrain ImagingDefault Mode Network Other More
Select for export Are "mystical experiences" essential for antidepressant actions of ketamine and the classic psychedelics? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00406-024-01770-7 PubMed 38411629 Copy citation Copy BibTeX Unknown journal 2024-02-26 Hashimoto K. Europe PMC Published psilocybin DepressionReceptor PharmacologyMystical Experience Clinical Trial More
Select for export Multimodal Neuroimaging of the Effect of Serotonergic Psychedelics on the Brain. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3174/ajnr.a8118 PubMed 38360790 Copy citation Copy BibTeX Unknown journal 2024-02-14 Frautschi PC, Singh AP, Stowe NA, Yu JJ. Europe PMC Published psilocybin DepressionPTSDAddiction Review Article More
Select for export Efficacy and acceptability of psilocybin for primary or secondary depression: A systematic review and meta-analysis of randomized controlled trials. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2024.1359088 PubMed 38426002 Copy citation Copy BibTeX Unknown journal 2024-02-14 Fang S, Yang X, Zhang W. Europe PMC Published psilocybin DepressionEnd-of-Life DistressClinical Trial Randomized Controlled Trial More
Select for export New evidence for flexible psilocybin dosing in patients with treatment-resistant depression No abstract availability was recorded for this entry. Details DOI 10.1016/j.medj.2024.01.014 PubMed 38359837 Copy citation Copy BibTeX Med 2024-02-13 Scott T. Aaronson, Zofia Kozak OpenAlex Published psilocybin DepressionPharmacologyTreatment-Resistant Depression Other More
Psilocybin-Research.com
Searchable psilocybin and psilocin bibliometric database.